ResearcherChongqing Medical UniversityNo recent work listed

Wei Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8368-7543; OpenAlex author ID A5100614422. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2015: 1 paper

Papers 1

Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway. Co-author DOI 10.1016/j.canlet.2014.10.008 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wei Zhang · 1 shared paper, 2015 · strength 0.05
- Paper Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the… DOI 10.1016/j.canlet.2014.10.008 ↗
Yuqiang Li · 1 shared paper, 2015 · strength 0.05
- Paper Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the… DOI 10.1016/j.canlet.2014.10.008 ↗
Yu-Cheng Tang · 1 shared paper, 2015 · strength 0.05
- Paper Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the… DOI 10.1016/j.canlet.2014.10.008 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.